Ladan Zand (@ladanzand) 's Twitter Profile
Ladan Zand

@ladanzand

Nephrologist. Interested in GN.

ID: 1166145581884039171

calendar_today27-08-2019 00:29:26

648 Tweet

1,1K Takipรงi

294 Takip Edilen

Nattawat Klomjit (@basmeomeo) 's Twitter Profile Photo

1. Is this MGRS? This is common when we see CKD patients with monoclonal gammopathy? Our work in KI can aid clinician in this situation! Let's dive in this paper! kidney-international.org/article/S0085-โ€ฆ Ladan Zand fernando fervenza Sanjeev Sethi Mayo Clinic Nephrology UMN Division of Nephrology & Hypertension American Society of Onconephrology

Mayo Clinic Nephrology (@mayoclinicneph) 's Twitter Profile Photo

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy Ladan Zand Nattawat Klomjit maria jose vargas Sanjeev Sethi fernando fervenza kidney-international.org/article/S0085-โ€ฆ

Mayo Clinic Nephrology (@mayoclinicneph) 's Twitter Profile Photo

Do you have crescentic IgA Nephropathy? You may qualify for a Mayo Clinic clinical trial evaluating a novel treatment for crescentic IgAN. โ€œAvacopan in Crescentic IgANโ€ Learn more and see if you are eligible: Link ๐Ÿ”— mayo.edu/research/cliniโ€ฆ fernando fervenza Ladan Zand

Mayo Clinic Nephrology (@mayoclinicneph) 's Twitter Profile Photo

Clinical trial at our Mayo Clinic Nephrology: Evaluating daratumumab for treatment of PGNMID (Proliferative Glomerulonephritis with Monoclonal Immune Deposits). A novel approach to a rare glomerular disease. fernando fervenza Ladan Zand Learn More๐Ÿ”— mayo.edu/research/cliniโ€ฆ

Maria Jose Soler (@pepasolerr) 's Twitter Profile Photo

๐ŸŽฅ๐ŸŽฅ๐ŸŽฅ โ€œ๐Ÿ๐ซ๐ฌ๐ญ ๐Œ๐š๐ฒ๐จ ๐‚๐ฅ๐ข๐ง๐ข๐œ - ๐•๐š๐ฅ๐ฅ ๐โ€™๐‡๐ž๐›๐ซ๐จ๐ง ๐๐„๐๐‡๐‘๐Ž๐‹๐Ž๐†๐˜ ๐”๐๐ƒ๐€๐“๐„โ€ save the dates 5-6 Sep Barcelona 2025. Register to [email protected] organized by Mayo Clinic Nephrology Nefrologia Hospital Universitari Vall d'Hebron Vall d'Hebron Sandra Herrmann MD, FASN oriol bestard fernando fervenza

Ladan Zand (@ladanzand) 's Twitter Profile Photo

In this multi-center study we describe 3 distinct phenotypes of patients with PLA2R-MN using unsupervised machine learning! โฆJing ^_^โฉ fernando fervenzaโฉ โฆShane Bobart, MD, FASNโฉ โฆWisit Cheungpasitporn MD FACP | FASN | FASTโฉ โฆMaria Jose Solerโฉ โฆNDTโฉ academic.oup.com/ndt/advance-arโ€ฆ

Maria Jose Soler (@pepasolerr) 's Twitter Profile Photo

๐ŸŽฅ๐ŸŽฅ๐ŸŽฅ โ€œ๐Ÿ๐ซ๐ฌ๐ญ ๐Œ๐š๐ฒ๐จ ๐‚๐ฅ๐ข๐ง๐ข๐œ - ๐•๐š๐ฅ๐ฅ ๐โ€™๐‡๐ž๐›๐ซ๐จ๐ง ๐๐„๐๐‡๐‘๐Ž๐‹๐Ž๐†๐˜ ๐”๐๐ƒ๐€๐“๐„โ€ 5-6 Sep Barcelona 2025. Register to [email protected] Mayo Clinic Nephrology Nefrologia Hospital Universitari Vall d'Hebron Vall d'Hebron Sandra Herrmann MD, FASN oriol bestard fernando fervenza Ladan Zand #andreaKattah